Type
. Repeatability of nerve thickness assessment in the clinical examination for leprosy. Leprosy review [Internet]. 1995;66(3):224-8. Available from: http://leprev.ilsl.br/pdfs/1995/v66n3/pdf/v66n3a06.pdf
Type
. Current concepts in the surgical management of lagophthalmos in leprosy. Leprosy review [Internet]. 1995;66(3):220-3. Available from: http://leprev.ilsl.br/pdfs/1995/v66n3/pdf/v66n3a05.pdf
Type
. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy. Leprosy review [Internet]. 1995;66(3):210-3. Available from: http://leprev.ilsl.br/pdfs/1995/v66n3/pdf/v66n3a03.pdf
Type
. Role of reactive oxygen species in renal damage in experimental leprosy. Leprosy review [Internet]. 1995;66(3):201-9. Available from: http://leprev.ilsl.br/pdfs/1995/v66n3/pdf/v66n3a02.pdf
Type
. Deformities and disabilities--unfinished agenda in leprosy work. Leprosy review [Internet]. 1995;66(3):193-200. Available from: http://leprev.ilsl.br/pdfs/1995/v66n3/pdf/v66n3a01.pdf
Type
. Coping with a chronic disease: the role of the mind and spirit. Patient education and counseling. 1995;26(1-3):107-12.
Type
. Addition of immunotherapy with Mycobacterium w vaccine to multi-drug therapy benefits multibacillary leprosy patients. Vaccine. 1995;13(12):1102-10.
Type
. Early detection of rifampin in human nerve tissue after an oral dose of 600 milligrams. Antimicrobial agents and chemotherapy. 1995;39(8):1866-70.
Type
. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science (New York, N.Y.). 1995;269(5221):227-30.
Type
. Leprosy. The beginning of an end to a public health problem?. Dermatologic clinics. 1995;13(3):525-36.